机译:制药行业的过程安全:一系列说明性案例研究
Pharmaceutical Development GlaxoSmithKline Upper Providence Pennsylvania 19426 United States;
Clinical Supply Chain GlaxoSmithKline Stevenage SG1 2NY United Kingdom;
Chemical Development GlaxoSmithKline Stevenage SG1 2NY United Kingdom;
Chemical Development GlaxoSmithKline Stevenage SG1 2NY United Kingdom;
Chemical Development GlaxoSmithKline Stevenage SG1 2NY United Kingdom;
Chemical Development GlaxoSmithKline Stevenage SG1 2NY United Kingdom;
Medicinal Chemistry GlaxoSmithKline Upper Providence Pennsylvania 19426 United States;
Clinical Supply Chain GlaxoSmithKline Upper Providence Pennsylvania 19426 United States;
Clinical Supply Chain GlaxoSmithKline Upper Providence Pennsylvania 19426 United States;
Graduate Education/Research; Upper-Division Undergraduate; Safety/Hazards; Problem Solving/Decision Making; Drugs/Pharmaceuticals; Industrial Chemistry; Thermal Analysis;
机译:基于模糊层次分析法的投资组合选择:以伊朗制药业为例
机译:澳大利亚红肉加工行业的有利可图和可持续的生物资源管理:批判性审查和说明性案例研究
机译:制药行业的供应商选择一种分析网络过程方法
机译:基于安全考虑的制药行业批量与连续过程的比较
机译:OSHA VPP安全干预措施在制药行业减少伤害和疾病发生率的有效性。
机译:更正:药物安全性:制药业的观点:更正:药物安全:制药业的观点
机译:基于模糊层次分析法的投资组合选择 - 以伊朗制药业为例
机译:行业指南:m3(R2)人体临床试验行为和药品营销许可的非临床安全性研究。问题与解答(R2),修订版1。